A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers

Trial Profile

A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2013

At a glance

  • Drugs ACHN 975 (Primary)
  • Indications Pseudomonal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jun 2013 Status changed from planning to recruiting, as reported by ClinicalTrials.gov.
    • 10 Jun 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 01 Jun 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top